Janjigian, YY, Werner, D, Pauligk, C, Steinmetz, K, Kelsen, DP, Jager, E (2012) Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis. Ann Oncol 23: pp. 2656-2662...
Microsatellite instability (MSI) has been widely acknowledged as an important factor regulating tumor intrinsic biological behavior and affecting the survival of gastric cancer patients. Here, we firstly identified the RARB as a gene associated with MSI gastric cancer. RARB was downregulated in human ...
Tumor gene expression is predictive of patient prognosis in some cancers. However, RNA-seq and whole genome sequencing data contain not only reads from host tumor and normal tissue, but also reads from the tumor microbiome, which can be used to infer the
AIM:To clarify the significance of combined resection of the spleen to dissect the No.10 lymph node(LN). METHODS:We studied 191 patients who had undergone total gastrectomy with splenectomy,excluding non-curative cases,resection of multiple gastric cancer, and those with remnant stomach cancer.Vario...
For more advanced cancers, functional status has consistently demonstrated an association with survival, although length of survival may depend on the underlying cancer. For example, for patients with metastatic cancer with relatively good treatment options, such as prostate or breast cancer, prognosis ...
Patients in which two or fewer proteins were expressed (group B) showed younger age, undifferentiated or diffuse type cancer, larger tumor size, larger number of metastatic lymph nodes, and more advanced stage than those in which three or more proteins were expressed (group A). In ...
Journal of Cellular BiochemistrymiRNA27a Is a Biomarker for Predicting Chemosensitivity and Prognosis in Metastatic or Recurrent Gastric Cancer[J] . Dingzhi Huang,Haiyan Wang,Rui Liu,Hongli Li,Shaohua Ge,Ming Bai,Ting Deng,Guangyu Yao,Yi Ba.J. Cell. Biochem. . 2014 (3)...
The prognosis of patients with metastatic gastric cancer is poor, with median survival ranging from 4 to 12 months, depending on the medical treatments applied4,5. Therefore, better management of advanced cancers, including gastric cancer, particularly through the use of new targeted therapeutic ...
Although significant progress has been made in its diagnosis and treatment, most patients are diagnosed with advanced GCa or metastatic cancer cells due to atypical symptoms of early GCa and insufficient attention to early screening [4]. Therefore, improving the efficiency of early screening is of ...
Although significant progress has been made in its diagnosis and treatment, most patients are diagnosed with advanced GCa or metastatic cancer cells due to atypical symptoms of early GCa and insufficient attention to early screening [4]. Therefore, improving the efficiency of early screening is of ...